TAG:
Siemens Healthineers
How Clinical Lab Leaders Can Take Advantage of C-Suite Priorities
CEO SUMMARY: A new industry survey by Siemens Healthineers indicates that hospital executives increasingly recognize medical laboratories as vital clinical assets. However, securing capital based on that good will require…
What Earnings Calls Reveal about Shifting IVD Pipelines
CEO SUMMARY: An examination of recent earnings reports from the top global in vitro diagnostics (IVD) companies uncovers three macro-trends that clinical laboratories should monitor. Among those tren…
Three Signals to Take from Executive War College
We’ve arrived back from New Orleans and the 3…
For IVD Companies, Tariff Refunds May Be a Long Haul
Following the US Supreme Court’s decision declaring certain tariffs illegal, the diagnostics industry has entered a murky period regarding potential refunds. For in vitro diagnostics (IVD) manufacturers who paid these tariffs under policies f…
Global IVD Woes in China Should Resonate with US Labs
In vitro diagnostics (IVD) companies reported a mix of overall growth, with many noting continuing challenges in their diagnostics divisions for recent quarterly financial results. Thermo Fisher Scientific, QuidelOrtho, and Danaher reported the…
Reforms in China Affect IVD Companies’ Q3 2025 Earnings
Most of the in vitro diagnostics (IVD) manufacturers that serve clinical laboratories worldwide reported facing financial “headwinds” in the China IVD market that affected their third-quarter performance. This was due to policy changes in the country…
October 6, 2025, Intelligence: Late-Breaking Lab News
Bloomberg News has reported that Siemens Healthineers is potentially exploring a sale of its diagnostics division. Several large private equity firms have held early talks with Siemens, including Blackstone, CVC Capital Partners, and KKR & Co., according to Bloomberg. Sourc…
2025 Ranking of the World’s Top 13 IVD Corporations
BASED ON PUBLICLY-REPORTED 2024 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) companies continue to dominate the global market, as they have for the last two years: Thermo Fisher Scientific, Roche, Danaher, and Abbott Laboratories. The top 13 companies …
Despite Trade Tariffs, IVD Firms Report Upbeat Earnings
LEADING IN VITRO DIAGNOSTICS (IVD) COMPANIES RECENTLY REPORTED POSITIVE QUARTERLY FINANCIALS despite swirling concerns about trade tariffs and cuts to US federal research grants. It’s not yet clear what the long-term effect of tariffs’ will be on IVD manu…
My Green Lab Prepares Full-Scale Entry into Diagnostics
AGAINST THE BACKDROP OF REDUCED SUSTAINABILITY INITIATIVES IN THE CORPORATE AND POLITICAL WORLDS, environmental stewardship remained a topic of discussion at the Association for Diagnostics and Laboratory Medicine’s (ADLM) 2025 conference. Among the more interesting announcements wa…
CURRENT ISSUE
Volume XXXIII, No. 10 – August 2026
In the August 2026 briefing, The Dark Report explains the relevance behind CMS potentially changing how it pays for “software as a medical service”. Other topics include a look into how health system executives view clinical labs, possible CLIA updates, and a 30/60/90-day approach to reducing reliance on traveling medical lab techs.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.